# CME Group Inc.: filings

CME · Nasdaq · CIK 1156375 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cme.md) · [Financials](/companies/cme/financials.md) · [Filings](/companies/cme/filings.md) · [Insiders](/companies/cme/insiders.md)

## Reports and events: 310 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1551, 8-K 213, DEFA14A 111, 144 70, 10-Q 54, 3 44, 4/A 39, 5 36, SC 13G/A 35, DEF 14A 20, 10-K 18, UPLOAD 16, 424B5 13, CORRESP 13, 425 11, ARS 11, NO ACT 10, CT ORDER 7, FWP 7, 3/A 6, S-3ASR 6, PRE 14A 5, SC 13G 5, S-8 4, S-4/A 3, 10-Q/A 2, 424B3 2, SC 13D 2, SCHEDULE 13G/A 2, 424B2 1, DEFR14A 1, EFFECT 1, IRANNOTICE 1, PX14A6G 1, S-4 1, S-8 POS 1, SC 13D/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 14:22 ET | [10-Q](/filings/0001156375-26-000068.md) | Quarterly report, period 2026-09-30 | 0001156375-26-000068 |
| 2026-10-21 | 07:13 ET | [8-K](/filings/0001156375-26-000065.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156375-26-000065 |
| 2026-09-25 | 16:08 ET | [8-K](/filings/0001156375-26-000060.md) | 5.03 Amendment to articles or bylaws | 0001156375-26-000060 |
| 2026-09-09 | 11:15 ET | [8-K](/filings/0001193125-26-386091.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-386091 |
| 2026-08-11 | 16:44 ET | [8-K](/filings/0001156375-26-000051.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001156375-26-000051 |
| 2026-07-24 | 14:43 ET | [10-Q](/filings/0001156375-26-000047.md) | Quarterly report, period 2026-06-30 | 0001156375-26-000047 |
| 2026-07-22 | 07:15 ET | [8-K](/filings/0001156375-26-000042.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156375-26-000042 |
| 2026-06-17 | 08:35 ET | [8-K](/filings/0001193125-26-273442.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-273442 |
| 2026-06-10 | 16:50 ET | [8-K](/filings/0001156375-26-000035.md) | 5.07 Shareholder vote results | 0001156375-26-000035 |
| 2026-05-19 | 16:21 ET | [8-K](/filings/0001156375-26-000028.md) | 5.07 Shareholder vote results | 0001156375-26-000028 |
| 2026-04-27 | 16:38 ET | [8-K](/filings/0001156375-26-000022.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001156375-26-000022 |
| 2026-04-24 | 14:38 ET | [10-Q](/filings/0001156375-26-000020.md) | Quarterly report, period 2026-03-31 | 0001156375-26-000020 |
| 2026-04-22 | 07:13 ET | [8-K](/filings/0001156375-26-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156375-26-000016 |
| 2026-03-23 | 16:11 ET | [DEF 14A](/filings/0001628280-26-020500.md) | Proxy statement, period 2025-12-31 | 0001628280-26-020500 |
| 2026-02-26 | 17:30 ET | [10-K](/filings/0001156375-26-000009.md) | Annual report, period 2025-12-31 | 0001156375-26-000009 |
| 2026-02-04 | 07:06 ET | [8-K](/filings/0001156375-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156375-26-000006 |
| 2026-02-02 | 09:31 ET | [8-K](/filings/0001156375-26-000002.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001156375-26-000002 |
| 2025-10-24 | 14:07 ET | [10-Q](/filings/0001156375-25-000206.md) | Quarterly report, period 2025-09-30 | 0001156375-25-000206 |
| 2025-10-22 | 07:05 ET | [8-K](/filings/0001156375-25-000204.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156375-25-000204 |
| 2025-09-11 | 12:06 ET | [8-K](/filings/0001156375-25-000190.md) | 5.02 Departure or appointment of officers or directors | 0001156375-25-000190 |
| 2025-07-25 | 16:19 ET | [8-K](/filings/0001156375-25-000184.md) | 8.01 Other events | 0001156375-25-000184 |
| 2025-07-25 | 20:01 ET | [10-Q](/filings/0001156375-25-000182.md) | Quarterly report, period 2025-06-30 | 0001156375-25-000182 |
| 2025-07-23 | 07:08 ET | [8-K](/filings/0001156375-25-000176.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156375-25-000176 |
| 2025-05-09 | 13:06 ET | [8-K](/filings/0001156375-25-000120.md) | 5.07 Shareholder vote results | 0001156375-25-000120 |
| 2025-04-30 | 14:50 ET | [10-Q](/filings/0001156375-25-000103.md) | Quarterly report, period 2025-03-31 | 0001156375-25-000103 |
| 2025-04-25 | 09:10 ET | [8-K](/filings/0001156375-25-000098.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001156375-25-000098 |
| 2025-04-23 | 07:07 ET | [8-K](/filings/0001156375-25-000093.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156375-25-000093 |
| 2025-04-14 | 08:35 ET | [8-K](/filings/0001193125-25-079725.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-079725 |
| 2025-03-20 | 16:03 ET | [DEF 14A](/filings/0001156375-25-000077.md) | Proxy statement, period 2025-03-20 | 0001156375-25-000077 |
| 2025-03-10 | 16:12 ET | [8-K](/filings/0001193125-25-050881.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-050881 |
| 2025-03-04 | 16:30 ET | [8-K](/filings/0001193125-25-045633.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-045633 |
| 2025-02-27 | 16:30 ET | [10-K](/filings/0001156375-25-000021.md) | Annual report, period 2024-12-31 | 0001156375-25-000021 |
| 2025-02-12 | 07:05 ET | [8-K](/filings/0001156375-25-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156375-25-000007 |
| 2024-12-11 | 09:16 ET | [8-K](/filings/0001193125-24-274928.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-274928 |
| 2024-12-05 | 07:42 ET | [8-K](/filings/0001193125-24-271111.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-271111 |
| 2024-11-08 | 15:23 ET | [10-Q](/filings/0001156375-24-000200.md) | Quarterly report, period 2024-09-30 | 0001156375-24-000200 |
| 2024-11-07 | 13:19 ET | [8-K](/filings/0001193125-24-252912.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-252912 |
| 2024-10-23 | 07:06 ET | [8-K](/filings/0001156375-24-000187.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156375-24-000187 |
| 2024-08-05 | 16:48 ET | [10-Q](/filings/0001156375-24-000149.md) | Quarterly report, period 2024-06-30 | 0001156375-24-000149 |
| 2024-07-24 | 07:10 ET | [8-K](/filings/0001156375-24-000143.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156375-24-000143 |
| 2024-07-08 | 10:09 ET | [8-K](/filings/0001193125-24-175987.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-175987 |
| 2024-05-13 | 08:48 ET | [8-K](/filings/0001193125-24-136767.md) | 5.07 Shareholder vote results | 0001193125-24-136767 |
| 2024-05-01 | 13:55 ET | [10-Q](/filings/0001156375-24-000072.md) | Quarterly report, period 2024-03-31 | 0001156375-24-000072 |
| 2024-04-25 | 15:51 ET | [8-K](/filings/0001193125-24-113786.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-113786 |
| 2024-04-24 | 07:05 ET | [8-K](/filings/0001156375-24-000070.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156375-24-000070 |
| 2024-03-18 | 16:07 ET | [DEF 14A](/filings/0001156375-24-000018.md) | Proxy statement, period 2023-12-31 | 0001156375-24-000018 |
| 2024-03-07 | 16:15 ET | [8-K](/filings/0001193125-24-062191.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-062191 |
| 2024-02-28 | 15:24 ET | [10-K](/filings/0001156375-24-000010.md) | Annual report, period 2023-12-31 | 0001156375-24-000010 |
| 2024-02-14 | 07:08 ET | [8-K](/filings/0001156375-24-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156375-24-000007 |
| 2023-12-06 | 17:29 ET | [8-K](/filings/0001193125-23-290001.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-290001 |

Page 1 of 7. [Older](/companies/cme/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:17 ET. No prices; not investment advice.